Delivery Order SPE2DR25D1004-SPE2DR26FTBL2

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for Depakote DR 125 mg sprinkle capsules (100-count), with a ceiling value of $1,132.64.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 19, 2026, and is priced on a firm fixed-price basis. No set-aside applied to this order.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 11, 2026, for $1,738.86 to supply Depakote DR 125 mg sprinkle capsules (100-count units).</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and ultimate completion date of March 12, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 3, 2026, with a ceiling value of $3,897.24 for supply of Depakote DR 125 mg sprinkle capsules (100-count units).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 4, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $2,815.86 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for DEPAKOTE DR 125 MG SPRINKLE CP 100S (NDC 4571130442). The order is firm fixed price with an ultimate completion date of March 13, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued without a set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, with a ceiling value of $1,000.17 for supply of Depakote ER 250 mg tablets (100 count). Place of performance is Conshohocken, PA. The order is due for ultimate completion on February 23, 2026. Pricing is firm fixed price under a no set-aside competitive award.</p>

<p>The Defense Logistics Agency issued a $1,954.80 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Depakote DR 500 mg tablets (100 count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is March 9, 2026. Pricing is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $1,062.03 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for DEPAKOTE ER 250 mg tablets (100 count). The order is firm fixed price with an ultimate completion date of February 24, 2026.</p> <p>Place of performance is Conshohocken, PA. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for $1,473.32 to supply DEPAKOTE DR 125 MG SPRINKLE CP 100S pharmaceutical product. The order was issued under the parent Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order has a...

The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $5,463.37. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Depakote DR 125 mg Sprinkle capsules (100-count) with a ceiling value of $1,314.68. This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...